Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)
$2.80
+0.1900 ( +7.28% ) 157.3K
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
Market Data
Open
$2.80
Previous close
$2.61
Volume
157.3K
Market cap
$108.97M
Day range
$2.61 - $2.84
52 week range
$1.07 - $3.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | May 13, 2024 |
4 | Insider transactions | 1 | May 13, 2024 |
8-k | 8K-related | 18 | May 07, 2024 |
10-k/a | Quarterly Reports | 13 | Apr 26, 2024 |
10-k | Annual reports | 81 | Mar 28, 2024 |
8-k | 8K-related | 13 | Mar 28, 2024 |
10-q | Quarterly Reports | 65 | Nov 09, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
8-k | 8K-related | 30 | Nov 02, 2023 |
4 | Insider transactions | 1 | Oct 03, 2023 |